The effect of the APOE genotype on the risk of AD is thought to be Aβ-mediated by its effects on Aβ, as the Aβ aggregation and plaque formation rates are ApoE isoform-dependent (ApoE4 > ApoE3 > ApoE2). Here, APOE is linked to Alzheimer disease.